KR910006489A - 세포외의 엑소폴리머 이것의 제조방법 및 그러한 엑소폴리머를 함유하는 제약학적 조성물 - Google Patents

세포외의 엑소폴리머 이것의 제조방법 및 그러한 엑소폴리머를 함유하는 제약학적 조성물 Download PDF

Info

Publication number
KR910006489A
KR910006489A KR1019900015336A KR900015336A KR910006489A KR 910006489 A KR910006489 A KR 910006489A KR 1019900015336 A KR1019900015336 A KR 1019900015336A KR 900015336 A KR900015336 A KR 900015336A KR 910006489 A KR910006489 A KR 910006489A
Authority
KR
South Korea
Prior art keywords
exopolymer
exopolymers
daltons
medium
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019900015336A
Other languages
English (en)
Korean (ko)
Inventor
파레스 파러스 레이몬
요프리 토로에라 주앙
리차드 진-폴
스쿨세스 아드리안
파린 진-클라우드
미켈렛 마리에-크리스틴
람스테이너 아그네스
바우어 잭커
Original Assignee
리차드 진-폴
래보래토이레스 오엠 소시에테 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리차드 진-폴, 래보래토이레스 오엠 소시에테 아노님 filed Critical 리차드 진-폴
Publication of KR910006489A publication Critical patent/KR910006489A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
KR1019900015336A 1989-09-29 1990-09-27 세포외의 엑소폴리머 이것의 제조방법 및 그러한 엑소폴리머를 함유하는 제약학적 조성물 Abandoned KR910006489A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3536/89 1989-09-29
CH3536/89A CH679677A5 (enExample) 1989-09-29 1989-09-29

Publications (1)

Publication Number Publication Date
KR910006489A true KR910006489A (ko) 1991-04-29

Family

ID=4258109

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900015336A Abandoned KR910006489A (ko) 1989-09-29 1990-09-27 세포외의 엑소폴리머 이것의 제조방법 및 그러한 엑소폴리머를 함유하는 제약학적 조성물

Country Status (37)

Country Link
US (1) US5114848A (enExample)
JP (1) JPH03170503A (enExample)
KR (1) KR910006489A (enExample)
AR (1) AR242263A1 (enExample)
AT (1) ATA188490A (enExample)
AU (1) AU644604B2 (enExample)
BE (1) BE1004569A3 (enExample)
BG (1) BG60275B2 (enExample)
BR (1) BR9004147A (enExample)
CA (1) CA2025155A1 (enExample)
CH (1) CH679677A5 (enExample)
CZ (1) CZ466590A3 (enExample)
DD (1) DD295764A5 (enExample)
DE (1) DE4028018A1 (enExample)
DK (1) DK191290A (enExample)
EG (1) EG19285A (enExample)
ES (1) ES2025972A6 (enExample)
FI (1) FI95483C (enExample)
FR (1) FR2652590B1 (enExample)
GB (1) GB2244998B (enExample)
GR (1) GR900100706A (enExample)
HU (1) HU210826B (enExample)
IT (1) IT1243709B (enExample)
LU (1) LU87809A1 (enExample)
MA (1) MA21945A1 (enExample)
NL (1) NL9001998A (enExample)
NO (1) NO178345C (enExample)
NZ (1) NZ235338A (enExample)
PE (1) PE15391A1 (enExample)
PL (1) PL165512B1 (enExample)
PT (1) PT95346A (enExample)
RU (2) RU2023445C1 (enExample)
SE (1) SE9002557L (enExample)
TN (1) TNSN90122A1 (enExample)
TR (1) TR25353A (enExample)
YU (1) YU47646B (enExample)
ZA (1) ZA906492B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1236463B1 (en) 2001-02-23 2007-01-03 Chemisches Laboratorium Dr. Kurt Richter GmbH Topical composition
RU2192874C1 (ru) * 2001-08-14 2002-11-20 Колганова Нина Алексеевна Концентрат для получения противоаллергического, противовоспалительного средства
WO2005034971A2 (en) * 2003-10-08 2005-04-21 Masami Moriyama Antiviral agent
RU2373957C2 (ru) 2006-10-13 2009-11-27 Александр Метталинович Тишин Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его
EP2176299B1 (en) * 2007-05-04 2017-07-05 Alimentary Health Limited Exopolysaccharide from bifidobacterium infantis 35624 (ncimb 41003)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103194A (en) * 1980-01-23 1981-08-18 Meiji Seika Kaisha Ltd Antitumor substance and its preparation
US4435389A (en) * 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JPS58203913A (ja) * 1982-05-25 1983-11-28 Meiji Milk Prod Co Ltd 高分子多糖類物質mps−82及びその利用
JPS59118712A (ja) * 1982-12-27 1984-07-09 Morinaga Milk Ind Co Ltd 抗腫瘍剤及びその製造法
JPS61257930A (ja) * 1985-05-09 1986-11-15 Morinaga Milk Ind Co Ltd 感染防御剤
US4701907C1 (en) * 1986-02-03 2002-08-27 Collins Mary Dynamically reconfigurable time-space-time digital switch and network
EP0295961A3 (en) * 1987-06-18 1989-07-12 Kureha Kagaku Kogyo Kabushiki Kaisha Polysaccharides and antiviral drug containing polysaccharides as active ingredient

Also Published As

Publication number Publication date
SE9002557D0 (sv) 1990-08-02
YU47646B (sh) 1995-12-04
PT95346A (pt) 1991-05-22
CH679677A5 (enExample) 1992-03-31
MA21945A1 (fr) 1991-04-01
JPH03170503A (ja) 1991-07-24
FR2652590A1 (fr) 1991-04-05
AU644604B2 (en) 1993-12-16
DK191290A (da) 1991-03-30
PE15391A1 (es) 1991-05-04
RU2025127C1 (ru) 1994-12-30
PL286821A1 (en) 1991-11-04
RU2023445C1 (ru) 1994-11-30
FI903777A0 (fi) 1990-07-27
NL9001998A (nl) 1991-04-16
DE4028018A1 (de) 1991-04-11
GB9020112D0 (en) 1990-10-24
IT9021332A1 (it) 1992-02-29
TNSN90122A1 (fr) 1991-03-05
HU210826B (en) 1995-08-28
EG19285A (en) 1994-10-30
SE9002557L (sv) 1991-03-01
BR9004147A (pt) 1991-09-03
NZ235338A (en) 1991-09-25
AU6263190A (en) 1991-04-11
BG60275B1 (bg) 1994-03-31
BG60275B2 (en) 1994-03-31
CA2025155A1 (en) 1991-03-30
TR25353A (tr) 1993-03-01
GB2244998A (en) 1991-12-18
HUT61333A (en) 1992-12-28
NO904041L (no) 1991-04-02
GB2244998B (en) 1993-10-06
US5114848A (en) 1992-05-19
HU905988D0 (en) 1991-03-28
GR900100706A (el) 1992-01-20
NO178345C (no) 1996-03-06
IT9021332A0 (it) 1990-08-29
ZA906492B (en) 1991-05-29
BE1004569A3 (fr) 1992-12-15
CZ466590A3 (en) 1997-03-12
NO904041D0 (no) 1990-09-17
NO178345B (no) 1995-11-27
LU87809A1 (fr) 1991-02-18
YU156990A (sh) 1992-12-21
FR2652590B1 (fr) 1993-06-25
DD295764A5 (de) 1991-11-14
FI95483C (fi) 1996-02-12
ES2025972A6 (es) 1992-04-01
DK191290D0 (da) 1990-08-10
FI95483B (fi) 1995-10-31
IT1243709B (it) 1994-06-21
ATA188490A (de) 1997-05-15
AR242263A1 (es) 1993-03-31
PL165512B1 (pl) 1994-12-30

Similar Documents

Publication Publication Date Title
KR850004983A (ko) 고순도 히알우론산의 제조방법
NO160146C (no) Fremgangsmaate for fremstilling av hyaluronsyre fra en bakteriekultur av streptococcus pyogenes type 18.
PT103714A (pt) Polímero à base de galactose, processo para a sua obtenção e respectivas utilizações
CN102174614B (zh) 一种能提高机体免疫力的南极适冷微生物胞外多糖
US6344346B1 (en) Polysaccharide, micro-organism and method for obtaining same, composition containing it and application
CN108165512A (zh) 一种产胞外多糖空间植物乳杆菌ss18-119及其在提高生物抗氧化活性中的应用
Johnson et al. Morphological study of Streptococcus mutans and two extracellular polysaccharide mutants
KR910006489A (ko) 세포외의 엑소폴리머 이것의 제조방법 및 그러한 엑소폴리머를 함유하는 제약학적 조성물
Cooper et al. Enzyme formation and polysaccharide synthesis by bacteria: Polysaccharides produced by “nitrogen-fixing” organisms
CN115820436A (zh) 一种提高灵芝菌丝体多糖的方法
DE69831864T2 (de) Meeres-bakterienstamm der gattung vibrio, davon hergestellte wasserlösliche polysaccharide und deren verwendung
CN107739721A (zh) 产琼胶降解酶的芽孢杆菌Bacillus sp.W2017及其应用
KR100302505B1 (ko) 유산균 발효액 및 이를 함유하는 화장료 조성물
CN114874921B (zh) 一种南极来源的出芽短梗霉和其应用
KR102336328B1 (ko) 고체 원물이 포함된 바이오셀룰로오스, 이를 제조하기 위한 배지 조성물 및 이의 제조방법
JPH10237105A (ja) 多糖類、その製造方法及びこれを配合した化粧品
JPH1025234A (ja) 化粧料
KR100501730B1 (ko) 오레오바시디움 속 신균주 brd-109(기탁번호:kctc10182bp) 및 본 균주가 생산하는 베타-글루칸 생산방법
JP2693789B2 (ja) 多糖類及びその製造方法
CN114350725B (zh) 一种酵母菌胞外多糖、制备方法及其应用
CA1202812A (en) Conversion of clarified dairy whey lactose permeates to culture media and other commercially useful products
JPH0223864A (ja) ラクトバチルスsp.KPB−167及びそれによる粘性多糖類の製法
Fitzgerald et al. Helically coiled micro-organism from caecum contents of the rat
JPS61236790A (ja) ガラクトオリゴ糖の製造法
JPH03130073A (ja) 新規アシネトバクター・カルコアセティカス及び新規バイオサーファクタント

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19900927

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19941230

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19900927

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19971121

Patent event code: PE09021S01D

PC1902 Submission of document of abandonment before decision of registration
SUBM Surrender of laid-open application requested